New potential anti-SARS-CoV-2 and anti-cancer therapies of chitosan derivatives and its nanoparticles: Preparation and characterization

被引:11
|
作者
Ali, Mai [1 ]
Mohamed, Mansoura I. [2 ]
Taher, Azza T. [3 ,4 ]
Mahmoud, Sara H. [5 ]
Mostafa, Ahmed [5 ]
Sherbiny, Farag F. [6 ,7 ,8 ]
Kandile, Nadia G. [2 ]
Mohamed, Hemat M. [2 ]
机构
[1] October 6 Univ O6U, Fac Pharm, Dept Chem, October 6 City 12585, Giza, Egypt
[2] Ain Shams Univ, Fac Women Art Sci & Educ, Chem Dept, Cairo 11757, Egypt
[3] Cairo Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Cairo 11562, Egypt
[4] October 6 Univ O6U, Fac Pharm, Dept Pharmaceut Organ Chem, October 6 City 12585, Giza, Egypt
[5] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza 12622, Egypt
[6] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Organ Chem Dept, Cairo 11884, Egypt
[7] Misr Univ Sci & Technol MUST, Basic Sci Ctr, Dept Chem, 6th Of The October City 77, Egypt
[8] Misr Univ Sci & Technol MUST, Pharmaceut Organ Chem Coll Pharmaceut Sci & Drug M, 6th Of The October City, Egypt
关键词
Chitosan and chitosan NP?s derivatives; COVID-19; Anticancer; Molecular docking; ANTIVIRAL ACTIVITY; DESIGN; ISATIN;
D O I
10.1016/j.arabjc.2023.104676
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chitosan (CS) is a biopolymer and has reactive amine/hydroxyl groups facilitated its modifications. The purpose of this study is improvement of (CS) physicochemical properties and its capabilities as antiviral and antitumor through modification with 1-(2-oxoindolin-3-ylidene)thio semicarbazide (3A) or 1-(5-fluoro-2-oxoindolin-3-ylidene)thiosemicarbazide (3B) via crosslinking of poly(ethylene glycol)diglycidylether (PEGDGE) using microwave-assisted as green technique gives (CS-I) and (CS-II) derivatives. However, (CS) derivatives nanoparticles (CS-I NPs) and (CS-II NPs) are synthesized via ionic gelation technique using sodium tripolyphosphate (TPP). Structures of new (CS) derivatives are characterized using different tools. The anticancer, antiviral efficiencies and molecular docking of (CS) and its derivatives are assayed. (CS) derivatives and its nanoparticles
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
    Tan, Rebecca Shu Ling
    Hassandarvish, Pouya
    Chee, Chin Fei
    Chan, Lai Wah
    Wong, Tin Wui
    CARBOHYDRATE POLYMERS, 2022, 290
  • [2] Potential Anti-SARS-CoV-2 Molecular Strategies
    Vicidomini, Caterina
    Roviello, Giovanni N.
    MOLECULES, 2023, 28 (05):
  • [3] Anti-SARS-CoV-2 Potential of Artemisinins In Vitro
    Cao, Ruiyuan
    Hu, Hengrui
    Li, Yufeng
    Wang, Xi
    Xu, Mingyue
    Liu, Jia
    Zhang, Huanyu
    Yan, Yunzheng
    Zhao, Lei
    Li, Wei
    Zhang, Tianhong
    Xiao, Dian
    Guo, Xiaojia
    Li, Yuexiang
    Yang, Jingjing
    Hu, Zhihong
    Wang, Manli
    Zhong, Wu
    ACS INFECTIOUS DISEASES, 2020, 6 (09): : 2524 - 2531
  • [4] A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
    Wang, Juan
    Liang, Boqiang
    Chen, Yiling
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    Ye, Hui
    Nie, Linlin
    Zhou, Jiao
    Wu, Yi
    Wu, Meixian
    Huang, Lina S.
    An, Jing
    Warshel, Arieh
    Yuen, Kwok-Yung
    Ciechanover, Aaron
    Huang, Ziwei
    Xu, Yan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 215
  • [5] Design, synthesis and computational study of benzimidazole derivatives as potential anti-SARS-CoV-2 agents
    Ananta, Mokaddas Flora
    Saha, Poushali
    Rahman, Fahad Imtiaz
    Spriha, Sabiha Enam
    Chowdhury, A. K. Azad
    Rahman, S. M. Abdur
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1306
  • [6] Antiviral and Anti-SARS-CoV-2 Activity of Natural Chlorogenic Acid and Its Synthetic Derivatives
    Aljehany, Buthaina Mohammed
    ARCHIVES OF PHARMACY PRACTICE, 2022, 13 (04) : 74 - 81
  • [7] Detection of Anti-SARS-CoV-2 Antibodies
    Jahrsdoerfer, Bernd
    Schrezenmeier, Hubert
    TRANSFUSIONSMEDIZIN, 2021, 11 (03) : 182 - 187
  • [8] Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs
    Merarchi, Myriam
    Dudha, Namrata
    Das, Bhudev C.
    Garg, Manoj
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5384 - 5396
  • [9] Sofosbuvir may be a potential anti-sars-cov-2 rdrp drug
    Ibrahim M.N.
    Elfiky A.A.
    American Journal of Biochemistry and Biotechnology, 2021, 17 (02): : 205 - 207
  • [10] Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation
    Wan, Yichao
    Fang, Guoqing
    Chen, Hongjuan
    Deng, Xu
    Tang, Zilong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226